InnovAge Holding Corp. reported Q4 revenue that significantly surpassed analyst estimates and provided strong fiscal 2027 guidance, leading to a substantial after-hours stock jump. While EPS missed slightly, the robust revenue growth, net income turnaround, and improved Adjusted EBITDA margins signal a positive financial trajectory for the company.
InnovAge Holding Corp. announced its fiscal fourth-quarter results, with revenue of $261.95 million significantly exceeding analyst estimates of $238.28 million. This strong top-line performance, coupled with a turnaround from a net loss to a net income of $9.8 million and improved Adjusted EBITDA margins, is the primary driver for the after-hours stock surge. Although earnings per share slightly missed estimates, the market is clearly focusing on the revenue beat and the positive full-year performance, which saw a 98% decrease in net loss. The company's fiscal 2027 revenue and Adjusted EBITDA guidance further reinforces investor confidence, suggesting continued growth. For traders, this presents a short-term opportunity on the upside due to the positive surprise, with long-term implications tied to the company's ability to sustain revenue growth and profitability in the senior healthcare sector.